<--- Back to Details
First PageDocument Content
Mir-205 / Mir-184 / Mir-200 / Exosome / Cetuximab / MiR-122 / Mir-22 / Non-coding RNA / Non-small-cell lung carcinoma / MicroRNA / Genetics / Biology
Mir-205
Mir-184
Mir-200
Exosome
Cetuximab
MiR-122
Mir-22
Non-coding RNA
Non-small-cell lung carcinoma
MicroRNA
Genetics
Biology

Add to Reading List

Source URL: www.genomebiology.com

Download Document from Source Website

File Size: 303,11 KB

Share Document on Facebook

Similar Documents

MiR-122 / Non-coding RNA / MiR-191 / Mir-200 / Mir-2 microRNA precursor / Mir-48 / MiR-214 / Mir-92 microRNA precursor family / Mir-199 microRNA precursor / MicroRNA / Genetics / Mir-126

Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis

DocID: 19W6r - View Document

Mir-205 / Mir-126 / Mir-22 / Mir-137 / MiR-203 / Mir-145 / Non-small-cell lung carcinoma / Mir-200 / Mir-48 / MicroRNA / Genetics / MiR-122

Article in press - uncorrected proof Clin Chem Lab Med 2011;49(10):xxx-xxx  2011 by Walter de Gruyter • Berlin • Boston. DOICCLMReview Prognostic, therapeutic and diagnostic potential of microRNA

DocID: 19zws - View Document

Mir-184 / Mir-145 / MiR-122 / Mir-126 / Mir-22 / Non-coding RNA / Mir-200 / MiR-138 / Mir-127 / MicroRNA / Genetics / Biology

Downloaded from rnajournal.cshlp.org on July 28, Published by Cold Spring Harbor Laboratory Press Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell Georgia Sotiropoulo

DocID: 199TC - View Document

MiR-27 / Mir-223 / Mir-31 / MiR-214 / Mir-48 / MiR-138 / MiR-296 / Mir-200 / Mir-22 / MicroRNA / Mir-126 / MiR-122

miRNAs in macrophages and adipocytes - Supplemental Tables Table S1 Most significant differences regarding miRNAs availability in macrophages (M1) and adipocytes (MAs) and into supernatants (SN) at the basal level and u

DocID: 175SZ - View Document

MicroRNA / Non-coding RNA / RNA / European Association for the Study of the Liver / Hepatitis C virus / Genetics / Biology / MiR-122

A Single Subcutaneous Dose of 2 mg/kg or 4 mg/kg of RG-101, a GalNAc-Conjugated Oligonucleotide with Antagonist Activity against miR-122, Results in Significant Viral Load Reductions in Chronic Hepatitis C Patients

DocID: 160Pd - View Document